Effect of bosentan in patients with pulmonary arterial hypertension related to congenital heart disease with and without Down's syndrome

被引：0
|
作者：
D'alto, M. [1 ]
Romeo, E. [1 ]
Argiento, P. [1 ]
Sarubbi, B. [1 ]
Scognamiglio, G. [1 ]
Grimaldi, N. [1 ]
Correra, A. [1 ]
Russo, M. G. [1 ]
Calabro, R. [1 ]
机构：
[1] Univ Naples 2, Monaldi Hosp, Dept Cardiol, Naples, Italy
来源：
EUROPEAN HEART JOURNAL | 2010年 / 31卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：764 / 764
页数：1
相关论文
共 50 条
  • [1] Efficacy and safety of oral bosentan in patients with Down's syndrome and pulmonary arterial hypertension due to congenital heart disease
    D'Alto, Michele
    Romeo, Emanuele
    Argiento, Paola
    Correra, Anna
    Sarubbi, Berardo
    Pignatiello, Maria
    Caronna, Antonietta
    Vizza, Carmine Dario
    Calabro, Raffaele
    Russo, Maria Giovanna
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2012, 40
  • [2] Effect of Bosentan on Exercise Capacity and Quality of Life in Adults With Pulmonary Arterial Hypertension Associated With Congenital Heart Disease With and Without Down's Syndrome
    Duffels, Marielle G. J.
    Vis, Jeroen C.
    van Loon, Rosa L. E.
    Nieuwkerk, Pythia T.
    van Dijk, Arie P. J.
    Hoendermis, Elke S.
    de Bruin-Bon, Rianne H. A. C. M.
    Bouma, Berto J.
    Bresser, Paul
    Berger, Rolf M. F.
    Mulder, Barbara J. M.
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2009, 103 (09): : 1309 - 1315
  • [3] Effect of bosentan in children with pulmonary arterial hypertension associated with congenital heart disease
    Rosenzweig, E. Berman
    Ivy, D. D.
    Doran, A. K.
    Claussen, L. R.
    Yung, D.
    Widlitz, A. C.
    Abman, S.
    Barst, R. J.
    [J]. EUROPEAN HEART JOURNAL, 2006, 27 : 617 - 617
  • [4] Pulmonary arterial hypertension treatment with bosentan in pediatric patients with congenital heart disease
    Romero Jimenez, Rosa M.
    Garcia Sanchez, Raquel
    Gimenez Manzorro, Alvaro
    Martinez Fernandez-Llamazares, Cecilia
    Sanjurjo Saez, Maria
    [J]. PHARMACY WORLD & SCIENCE, 2009, 31 (02): : 347 - 347
  • [5] Therapy for pulmonary arterial hypertension due to congenital heart disease and Down's syndrome
    D'Alto, Michele
    Romeo, Emanuele
    Argiento, Paola
    D'Andrea, Antonello
    Sarubbi, Berardo
    Correra, Anna
    Scognamiglio, Giancarlo
    Papa, Silvia
    Bossone, Eduardo
    Calabro, Raffaele
    Vizza, Carmine D.
    Russo, Maria G.
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2013, 164 (03) : 323 - 326
  • [6] Efficacy of bosentan in a small cohort of adult patients with pulmonary arterial hypertension related to congenital heart disease
    Benza, RL
    Rayburn, BK
    Tallaj, JA
    Coffey, CS
    Pinderski, LJ
    Parnoukian, SV
    Bourge, RC
    [J]. CHEST, 2006, 129 (04) : 1009 - 1015
  • [7] EFFICACY AND SAFETY OF BOSENTAN IN PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION SECONDARY TO CONGENITAL HEART DISEASE
    Meng Lili
    Zhu Xianyang
    Zhang Duanzhen
    [J]. HEART, 2013, 99 : A42 - A42
  • [8] What Causes Pulmonary Arterial Hypertension in Down Syndrome With Congenital Heart Disease?
    Hosokawa, Susumu
    Vanderpool, Rebecca R.
    Ishii, Taku
    Nishiyama, Mitsunori
    Doi, Shozaburo
    [J]. CIRCULATION JOURNAL, 2018, 82 (06) : 1513 - 1514
  • [9] Treatment of Patients with Severe Pulmonary Arterial Hypertension Secondary to Congenital Heart Disease with Bosentan and Sildenafil
    Zhu, Xianyang
    Zhang, Duanzhen
    Meng, Jing
    Sheng, Xiaotang
    [J]. CIRCULATION, 2010, 122 (02) : E238 - E238
  • [10] Effect of the oral endothelin antagonist bosentan on the clinical, exercise, and haemodynamic status of patients with pulmonary arterial hypertension related to congenital heart disease
    Apostolopoulou, SC
    Manginas, A
    Cokkinos, DV
    Rammos, S
    [J]. HEART, 2005, 91 (11) : 1447 - 1452
12345